{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:00:07Z","timestamp":1772604007419,"version":"3.50.1"},"reference-count":55,"publisher":"The Endocrine Society","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 AR067854"],"award-info":[{"award-number":["K08 AR067854"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR061376"],"award-info":[{"award-number":["R01 AR061376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR 072650"],"award-info":[{"award-number":["R01 AR 072650"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AR061313"],"award-info":[{"award-number":["P30 AR061313"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1210\/en.2018-00174","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T18:03:39Z","timestamp":1522865019000},"page":"2165-2172","source":"Crossref","is-referenced-by-count":54,"title":["Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH"],"prefix":"10.1210","volume":"159","author":[{"given":"Eva S","family":"Liu","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robrecht","family":"Thoonen","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Petit","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binglan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel S","family":"Buys","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"Scherrer-Crosbie","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie B","family":"Demay","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"issue":"5","key":"2019041122063781200_B1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2783","article-title":"1,25-Dihydroxyvitamin D alone improves skeletal growth, microarchitecture and strength in a murine model of XLH, despite enhanced FGF23 expression","volume":"31","author":"Liu","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041122063781200_B2","first-page":"790","article-title":"Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets","volume":"60","author":"Holm","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"17","key":"2019041122063781200_B3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"2019041122063781200_B4","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"2019041122063781200_B5","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7120","key":"2019041122063781200_B6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"2","key":"2019041122063781200_B7","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2019041122063781200_B8","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00232.2013","article-title":"Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4","volume":"306","author":"Gattineni","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"2019041122063781200_B9","doi-asserted-by":"crossref","first-page":"e72816","DOI":"10.1371\/journal.pone.0072816","article-title":"FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues","volume":"8","author":"Chanakul","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"2019041122063781200_B10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2186","article-title":"Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice","volume":"29","author":"Ohata","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"22","key":"2019041122063781200_B11","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"issue":"5","key":"2019041122063781200_B12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"2019041122063781200_B13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM198709243171302","article-title":"Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy","volume":"317","author":"McLenachan","year":"1987","journal-title":"N Engl J Med"},{"issue":"12","key":"2019041122063781200_B14","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/eurheartj\/14.12.1622","article-title":"Left ventricular hypertrophy and myocardial ischaemia in hypertension: the THAMES Study","volume":"14","author":"Otterstad","year":"1993","journal-title":"Eur Heart J"},{"issue":"13","key":"2019041122063781200_B15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"2019041122063781200_B16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4","key":"2019041122063781200_B17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000435838","article-title":"Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment","volume":"5","author":"Di Lullo","year":"2015","journal-title":"Cardiorenal Med"},{"issue":"2","key":"2019041122063781200_B18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","article-title":"Left ventricular hypertrophy in nondiabetic predialysis CKD","volume":"46","author":"Paoletti","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2019041122063781200_B19","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/01.ASN.0000130566.69170.5E","article-title":"Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease","volume":"15","author":"McMahon","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"17","key":"2019041122063781200_B20","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"2019041122063781200_B21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1681\/ASN.2006070771","article-title":"Metabolic bone disease in chronic kidney disease","volume":"18","author":"Martin","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2019041122063781200_B22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/138161211795049787","article-title":"Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease","volume":"17","author":"Navab","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"19","key":"2019041122063781200_B23","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"2019041122063781200_B24","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"2019041122063781200_B25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"issue":"6","key":"2019041122063781200_B26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2019041122063781200_B27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/endo-111-3-904","article-title":"Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse","volume":"111","author":"Marie","year":"1982","journal-title":"Endocrinology"},{"issue":"15","key":"2019041122063781200_B28","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.107.729137","article-title":"Inhaled nitric oxide enables artificial blood transfusion without hypertension","volume":"117","author":"Yu","year":"2008","journal-title":"Circulation"},{"key":"2019041122063781200_B29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.yjmcc.2015.05.002","article-title":"Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy","volume":"84","author":"Thoonen","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"3 Pt 2","key":"2019041122063781200_B30","first-page":"H986","article-title":"Echocardiographic determination of risk area size in a murine model of myocardial ischemia","volume":"277","author":"Scherrer-Crosbie","year":"1999","journal-title":"Am J Physiol"},{"issue":"9","key":"2019041122063781200_B31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.echo.2004.05.014","article-title":"Relationship of systolic dysfunction to area at risk and infarction size after ischemia-reperfusion in mice","volume":"17","author":"Rodrigues","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"2019041122063781200_B32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"24","key":"2019041122063781200_B33","doi-asserted-by":"crossref","first-page":"18270","DOI":"10.1074\/jbc.M109.098616","article-title":"Phosphate-induced apoptosis of hypertrophic chondrocytes is associated with a decrease in mitochondrial membrane potential and is dependent upon Erk1\/2 phosphorylation","volume":"285","author":"Miedlich","year":"2010","journal-title":"J Biol Chem"},{"issue":"10","key":"2019041122063781200_B34","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1210\/en.2014-1315","article-title":"Phosphate interacts with PTHrP to regulate endochondral bone formation","volume":"155","author":"Liu","year":"2014","journal-title":"Endocrinology"},{"issue":"4727","key":"2019041122063781200_B35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1126\/science.2414846","article-title":"Plasticity of the differentiated state","volume":"230","author":"Blau","year":"1985","journal-title":"Science"},{"issue":"6","key":"2019041122063781200_B36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"27","key":"2019041122063781200_B37","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","article-title":"Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes","volume":"102","author":"Sabbagh","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019041122063781200_B38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.molmet.2015.09.004","article-title":"The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle","volume":"4","author":"Dyar","year":"2015","journal-title":"Mol Metab"},{"issue":"1","key":"2019041122063781200_B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2003.10.008","article-title":"Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development","volume":"266","author":"Schulz","year":"2004","journal-title":"Dev Biol"},{"issue":"1","key":"2019041122063781200_B40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.ph.55.030193.000415","article-title":"Control of cardiac gene expression by mechanical stress","volume":"55","author":"Komuro","year":"1993","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"2019041122063781200_B41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"issue":"5","key":"2019041122063781200_B42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.5650050508","article-title":"Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a Doppler echocardiography study","volume":"5","author":"Vered","year":"1990","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041122063781200_B43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/07435800.2016.1242604","article-title":"Patients with FGF23-related hypophosphatemic rickets\/osteomalacia do not present with left ventricular hypertrophy","volume":"42","author":"Takashi","year":"2017","journal-title":"Endocr Res"},{"issue":"8","key":"2019041122063781200_B44","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1210\/jcem.82.8.4181","article-title":"Cardiovascular abnormalities in patients with X-linked hypophosphatemia","volume":"82","author":"Nehgme","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122063781200_B45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.2017040412","article-title":"Cardiovascular effects of renal distal tubule deletion of the FGF receptor 1 gene","volume":"29","author":"Han","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2019041122063781200_B46","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"issue":"11","key":"2019041122063781200_B47","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"issue":"2","key":"2019041122063781200_B48","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","article-title":"Pathogenic role of Fgf23 in Dmp1-null mice","volume":"295","author":"Liu","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122063781200_B49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fphys.2016.00173","article-title":"Skeletal muscle, but not cardiovascular function, is altered in a mouse model of autosomal recessive hypophosphatemic rickets","volume":"7","author":"Wacker","year":"2016","journal-title":"Front Physiol"},{"issue":"5","key":"2019041122063781200_B50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1113\/expphysiol.1998.sp004140","article-title":"Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats","volume":"83","author":"Scheinowitz","year":"1998","journal-title":"Exp Physiol"},{"issue":"5","key":"2019041122063781200_B51","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.RES.81.5.679","article-title":"Trophic effect of human pericardial fluid on adult cardiac myocytes: differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy","volume":"81","author":"Corda","year":"1997","journal-title":"Circ Res"},{"issue":"12","key":"2019041122063781200_B52","doi-asserted-by":"crossref","first-page":"e82979","DOI":"10.1371\/journal.pone.0082979","article-title":"Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy","volume":"8","author":"Cilvik","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"2019041122063781200_B53","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"issue":"4","key":"2019041122063781200_B54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.71.4.559","article-title":"Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets","volume":"71","author":"Chesney","year":"1983","journal-title":"Pediatrics"},{"issue":"8","key":"2019041122063781200_B55","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/5\/2165\/25085913\/en.2018-00174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T02:18:23Z","timestamp":1660789103000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/5\/2165\/4960919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,4]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2018-00174","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,4,4]]}}}